Poly Cystic Ovary Syndrome
6
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
33%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
The Effect Of Polycystic Ovarian Syndrome Treatment On Ocular Surface.
Effectiveness of Hatha Yoga With and Without Zumba Exercise on Clinical Outcomes in Females With Poly Cystic Ovarian Syndrome
Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome
Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome
Therapeutic Role of Flax Seed for Poly Cystic Ovary Syndrome
Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome